“I can confirm we've submitted data on the efficacy of the vaccine in 12 to 15 years olds for review by UK MHRA,” the spokesman told Reuters by e-mail. The move comes a day after US regulators authorised the vaccine made by Pfizer and BioNTech SE for use in children as young as 12.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: